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Abstract
The nanostructure and nanomechanical properties of aggrecan monomers extracted and purified
from human articular cartilage from donors of different ages (newborn, 29 and 38 year old) were
directly visualized and quantified via atomic force microscopy(AFM)-based imaging and force
spectroscopy. AFM imaging enabled direct comparison of full length monomers at different ages.
The higher proportion of aggrecan fragments observed in adult versus newborn populations is
consistent with the cumulative proteolysis of aggrecan known to occur in vivo. The decreased
dimensions of adult full length aggrecan (including core protein and glycosaminoglycan (GAG)
chain trace length, end-to-end distance and extension ratio) reflect altered aggrecan biosynthesis.
The demonstrably shorter GAG chains observed in adult full length aggrecan monomers,
compared to newborn monomers, also reflects markedly altered biosynthesis with age. Direct
visualization of aggrecan subjected to chondroitinase and/or keratanase treatment revealed
conformational properties of aggrecan monomers associated with chondroitin sulfate (CS) and
keratan sulfate (KS) GAG chains. Furthermore, compressive stiffness of chemically end-attached
layers of adult and newborn aggrecan was measured in various ionic strength aqueous solutions.
Adult aggrecan was significantly weaker in compression than newborn aggrecan even at the same
total GAG density and bath ionic strength, suggesting the importance of both electrostatic and
non-electrostatic interactions in nanomechanical stiffness. These results provide molecular-level
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evidence of the effects of age on the conformational and nanomechanical properties of aggrecan,
with direct implications for the effects of aggrecan nanostructure on the age-dependence of
cartilage tissue biomechanical and osmotic properties.
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1. Introduction
Aggrecan, the most abundant proteoglycan in the extracellular matrix (ECM) of articular
cartilage, is composed of a ~250 kDa core protein (Tortorella et al., 2002) substituted with
~100 chondroitin sulfate (CS) and ~30 keratan sulfate (KS) glycosaminoglycan (GAG)
chains, as well as N-linked and O-linked oligosaccharides (Dudhia, 2005). In vivo, aggrecan
monomers form high molecular weight aggregates (> 200 MDa) by noncovalently binding
to hyaluronan (HA) stabilized by link protein (LP), which are enmeshed within a reinforcing
collagen fibrillar network (Muir, 1979). This hierarchically structured ECM determines the
unique biomechanical properties of cartilage, including load bearing and lubrication in
synovial joints (Maroudas, 1979). Age and disease-induced deterioration of human cartilage
(Hudelmaier et al., 2001) is characterized by significant structural heterogeneity of
aggrecan, including differences in core protein and GAG side chain length, KS and CS
substitution, and CS sulfate-ester substitution, which are critical determinants of cartilage
charge density and distribution (Bayliss and Ali, 1978; Dudhia, 2005; Plaas et al., 2001;
Plaas et al., 1997; Roughley and White, 1980). Progressive C-terminal truncation of the core
protein by proteolytic enzymes takes place with increasing maturation (Sandy and
Verscharen, 2001), and variations in aggrecan structure, in turn, can further affect its
susceptibility to proteolytic digestions and development of osteoarthritis (Roughley et al.,
2006).
Gel filtration chromatography and other biochemical assays have characterized age-related
changes in the mean values of aggrecan and GAG molecular weight, composition and
hydrodynamic size of large ensembles of cartilage-extracted aggrecan (Bayliss and Ali,
1978; Dudhia, 2005; Plaas et al., 2001; Plaas et al., 1997; Roughley and White, 1980). Such
measures, however, cannot define the structure of individual aggrecan monomers, the degree
of GAG variability within individual aggrecan, and the consequences of such ultrastructure
on aggrecan molecular mechanics, all of which can regulate the macroscopic biomechanical
and osmotic properties of articular cartilage as a function of age. This understanding could
fill the knowledge gap between the conventional macroscopic tissue measurements and the
underlying fundamental molecular-level properties of the matrix (Han et al., 2011; Hunziker
et al., 2002; Stolz et al., 2007), issues of great importance to disease progression and tissue
regeneration. High resolution imaging techniques, such as electron microscopy (Buckwalter
and Rosenberg, 1982; Buckwalter and Rosenberg, 1983; Buckwalter et al., 1994; Morgelin
et al., 1988; Rosenberg et al., 1975; Thyberg, 1977; Wiedemann et al., 1984) and atomic
force microscopy (AFM) (Fritz et al., 1997; Jarchow et al., 2000; Todd et al., 2003), have
shown the potential for examining aggrecan ultrastructure at the molecular level. We have
recently demonstrated that high resolution AFM imaging can directly visualize and quantify
the animal age and species-related variations in aggrecan ultrastructural features, such as the
spatial distribution and length heterogeneity of GAG side chains (Kopesky et al., 2010; Lee
et al., 2010; Ng et al., 2003). In addition, we have shown that AFM-based force
spectroscopy can relate these structural features to aggrecan nanomechanical properties and
their physical origins, such as ionic strength and [Ca2+] dependence, and thereby provide
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direct molecular evidence on the age-related changes in cartilage tissue functions (Dean et
al., 2006; Han et al., 2007a; Han et al., 2007b; Han et al., 2008).
Toward this end, the goal of this study was to quantify age-related changes in the structure
and nanomechanical properties of human aggrecan, and the role of CS- versus KS-GAGs in
aggrecan conformation. Firstly, AFM-based high resolution imaging was utilized to quantify
the structural and conformational parameters of individual aggrecan monomers extracted
from newborn and adult human articular cartilage. The age-related differences in
chondrocyte-mediated proteolytic and biosynthetic activities were distinguished for the first
time via direct visualizing of individual monomers. Secondly, via selective removal of KS
and/or CS GAG chains, we were able to distinguish the contributions of these GAG
components to the molecular structure and stiffness of aggrecan. Thirdly, the compressive
nanomechanical properties of aggrecan at different ages were evaluated via AFM-based
force spectroscopy to correlate molecular mechanical behavior to the observed aggrecan
nanostructures.
2. Materials and Methods
2.1 Isolation of human articular cartilage aggrecan
Macroscopically normal human articular cartilage samples were obtained at autopsy from
the femoral condyles of one newborn, one 29 year-old and one 38 year-old adult with whom
there was no evidence of arthritic disease or joint damage. Aggrecan was purified by
dissociative CsCl density gradient centrifugation from 4 M guanidine HCl extracts of the
cartilage, as described previously (Roughley and White, 1980). The initial dissociative (D1)
fractions of the newborn and 38 year-old human samples were subjected to a second
dissociative CsCl density gradient centrifugation, whereas part of the 29 year-old human
initial D1 fractions was treated with keratanase II or chondroitinase ABC prior to the second
dissociative density gradient centrifugation (see Section 2.2). The D1D1 fractions were then
dialyzed exhaustively against water, lyophilized, dissolved in water, and stored at −20°C in
1 mg/ml aliquots.
2.2 Keratanase and chondroitinase treatments of human aggrecan
Part of the initial D1 fractions of the 29 year-old human aggrecan samples were treated with
keratanase II or chondroitinase ABC in order to remove the KS- or CS-GAGs. The D1
fractions were first dissolved at 2 mg/ml in buffer. Aggrecan solution was then incubated at
37 °C for overnight with 5 mUnits keratanase II (Seikaguku, Tokyo, Japan) per mg aggrecan
and 50 mM sodium acetate at pH 6.0 for KS-GAG removal, and 50 mUnits chondroitinase
ABC (Seikagaku) per mg aggrecan, 100 mM Tris-HCl, 100 mM sodium acetate at pH 7.3
for CS-GAG removal. The digested samples were subsequently subjected to the second
dissociative CsCl density gradient centrifugation, dialyzed, and stored at −20°C in 1 mg/ml
aliquots.
2.3 AFM-based imaging and quantification of aggrecan structure
Aggrecan samples for AFM imaging were prepared following the procedures described
previously (Ng et al., 2003). Briefly, 50 µl aggrecan aliquots (~100 µg/mL) were deposited
on 3-aminopropyltriethoxysilane (APTES, Sigma Aldrich, St. Louis, MO) freshly treated
muscovite mica surfaces (SPI Supplies, West Chester, PA, #1804 V-5) for 20–30 min at
room temperature, rinsed gently with MilliQ water (18MΩ·cm resistivity, Purelab Plus UV/
UF, US Filter, Lowell, MA) and air dried. Tapping mode AFM imaging was carried out in
ambient conditions using rectangular Si AFM probe tips (AC240TS-2, Olympus, nominal
spring constant k = 2 N/m, nominal tip radius R < 10 nm) and the Nanoscope IIIA
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Multimode AFM (Veeco, Santa Barbara, CA). All imaging parameters were optimized to
acquire high quality images.
The AFM height images were digitized into pixels and the aggrecan core protein structure
features, including the trace lengths of core proteins LCP, and the end-to-end distance, Ree,
were traced automatically with a custom Matlab (Mathworks) program (Kopesky et al.,
2010). The trace lengths of the core protein, LCP, and the end-to-end distance, Ree, were
calculated according to the spatial coordinates of the traces. The trace lengths of the GAG
chains were traced manually with the SigmaScan Pro image analysis software (SPSS
Science, Chicago, IL). The extension ratio, Ree/LCP, was calculated as a measure to
demonstrate the degree of extension of each molecule. Nonparametric Mann-Whitney U-test
was performed to test the difference of their mean values between each pair of populations
without the assumption of normal distribution, with significance set at p < 0.05.
2.4 AFM-based nanomechanical test of aggrecan
Compressive nanomechanical properties of full length aggrecan were measured following
the procedures described previously (Dean et al., 2005). In short, micropatterned surfaces
with densely packed, chemically end-attached aggrecan and neutral, hydrophilic self-
assembled monolayer (OH-SAM, 11-mercaptoundecanol, HS(CH2)11OH, Sigma Aldrich)
were prepared via microcontact printing (Wilbur et al., 1994). A Multimode IV AFM with
the PicoForce piezo (Veeco) was utilized to perform compressive nanomechanical tests with
an OH-SAM functionalized, gold-coated spherical borosilicate colloidal probe tip
(Novascan, Ames, IA , k ~ 0.12 N/m, R ~ 2.5 µm).
Two measurements were employed to assess the mechanical stiffness of the aggrecan at
various ionic strengths. First, the compressed aggrecan layer height H was measured as a
function of applied normal force via contact mode AFM scanning across the aggrecan-OH-
SAM patterned surface at a given range of applied normal forces (0 ~ 30 nN) in NaCl
aqueous solutions (ionic strength, IS = 0.001 to 1.0 M, pH ~ 5.6, tip lateral displacement rate
= 60 µm/s). Secondly, aggrecan compression was performed by having the probe tip
approach perpendicularly to the end-grafted aggrecan layer (z-piezo displacement velocity =
2 µm/s). The pH values of the aqueous solutions used in nanomechanical tests were
measured to remain ~ 5.6 during the experiment (buffers were not used so that IS could be
controlled down to 0.001 via NaCl alone). Raw data were converted to normal force as a
function of tip-to-substrate distance, D, based on the height measurement (Dean et al.,
2006). Normal stresses were calculated from the normal force using the surface element
integration method (Bhattacharjee and Elimelech, 1997; Dean et al., 2006). The initial
sulfated GAG (sGAG, including both CS-GAG and KS-GAG) density prior to compression
as measured via the dimethylmethylene blue dye assay (Farndale et al., 1986), was ~ 20 mg/
ml (one aggrecan molecule per 25 nm × 25 nm surface area) at 0.1 M NaCl for both
newborn and adult cartilage aggrecan samples. sGAG density during compression was
calculated as a function of compressed height by normalizing the total sGAG content under
the probe tip to the reduced, compressed volume.
3. Results
3.1 Structural dimensions and heterogeneity of human aggrecan and constituent GAG
chains
Structure and conformation of individual aggrecan monomers were directly visualized and
the constituent GAG chains were clearly resolved in the AFM height images (Fig. 1). The
globular domains at the core protein N- or C-terminals are distinct in these images (Fig. 1a
and d, indicated by arrows). Aggrecan monomers consisting of globular domains at both
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ends were defined as full length aggrecan. The characterization of the full-length aggrecan
will be described in the following section.
In all the obtained images, newborn aggrecan were in general more uniform in size, whereas
adult aggrecan exhibited greater variations in terms of LCP. A greater portion of short
fragments (~100 nm) bearing globular domains were also observed in the 29 and 38 year-old
adult aggrecan populations (Fig. 1d,e). The short fragments are presumably the accumulated
fragments from the proteolytic processing (Lark et al., 1997; Yasumoto et al., 2003).
The mean and 95% confidence interval of the aggrecan structural parameters LCP, Ree and
Ree/LCP for each population are reported in Table 1. These data suggest that the newborn
population exhibits significantly larger values in all these parameters than either the 38 or 29
year old adult aggrecan populations (p < 0.01). In this study, we focused on the comparison
between the newborn and 38 year old populations (Figs. 2), as the comparison with the 29
year old population yielded the same conclusions.
The CS GAG chain length LGAG was found to be quite heterogeneous within one individual
newborn and adult aggrecan monomer (Fig 3a), and the mean LGAG of this individual
newborn monomer was significantly greater than that of the adult monomer (Table 2, Fig 3a,
p < 0.0001). These individual monomer LGAG distributions were then compared to LGAG for
the entire populations of newborn and 38 year old aggrecan (Fig. 3b), as well as the
identified full length monomers from these newborn and 38 year old aggrecan populations
(Fig. 3c). The distributions and mean values of the individual, full length and all observed
aggrecan populations were quite similar (Fig. 3), where GAG chains from the newborn
aggrecan were significantly longer (p < 0.0001, Table 2).
3.2 Nanostructure of keratanase and chondroitinase treated aggrecan
The structural analysis of the 29 year old aggrecan population focused on the roles of KS-
and CS-GAG chains on aggrecan structure and conformation. The keratanase II-treated
aggrecan appeared globally similar to the untreated aggrecan (Fig. 4a–d), consistent with the
presence of the many CS chains which are larger than KS. The chondroitinase ABC treated
aggrecan had a relatively long, GAG-free region of core protein, corresponding to the
position of the CS1 and CS2 domains, which occupy ~70% of the total aggrecan contour
length (Fig. 4e–f). However, shorter GAG chains were still visible, located near the globular
G1-G2 domains, corresponding to one of the putative locations of KS (Fig. 5).
Both KS- and CS-GAG removal resulted in significantly shorter LCP for aggrecan with the
full core proteins (Table 2 and Fig. 6a). Interestingly, the KS-removed aggrecan population
showed values of Ree and the extension ratio, Ree/LCP, similar to the those of the untreated
population, both of which were significantly greater than the CS-removed population (Table
2 and Fig. 6b, c). The comparison of LCP between full length and KS-removed aggrecan
including all observed aggrecan populations resulted in no statistical difference, likely
because the variations in LCP introduced by the fragments overshadow the shortening effects
of KS-removal on LCP.
3.3 Compressive nanomechanics of full-length aggrecan under fully hydrated conditions
Aggrecan height, H, was measured as a function of applied normal force in electrolyte baths
of 0.001 to 1.0 M NaCl. Consistent with previous observations on aggrecan from bovine and
equine cartilage (Dean et al., 2006; Lee et al., 2010), H decreased monotonically with
increasing applied normal force and ionic strength (Fig. 7a–d). The aggrecan heights
measured at low forces reflect the relative differences in the lengths and the degree of
extension of different aggrecan populations observed via AFM imaging (Fig. 7a,b). At all
the tested ionic strengths, the newborn human aggrecan exhibited significantly greater
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height than the 38-yr-old adult human aggrecan (Fig. 7a–d), consistent with the AFM
imaging measurements on the distribution of LCP, Ree and Ree/LCP (Fig. 2b–d).
In the force spectroscopy measurements, normal forces were then measured as a function of
the distance, D, between AFM probe tip and substrate. The normal force was found to
increase nonlinearly with decreasing the tip-substrate separation distance, D (Fig. 7e, f), also
consistent with previous observations (Dean et al., 2006; Lee et al., 2010). The newborn
aggrecan also displayed longer range repulsive forces than the adult aggrecan at any given
ionic strength, suggesting more superior compressive nanomechanical properties of newborn
aggrecan molecules. The compressive behavior assessed via the height and force
measurements coincide with each other, as shown for the measurements at 0.01 M ionic
strength (Fig. 7g). The differences between H and D at small normal forces (< 5 nN) may be
due to the tare force (~ 100 pN) necessary to enable stable feedback, and the additional
weaker shear resistance of aggrecan during the contact mode height measurement (Han et
al., 2007a).
The aggrecan compressive behavior of newborn and 38 year old aggrecan populations were
directly compared at near-physiologic ionic strength, 0.10 M. The force-distance curves
were converted to stress versus sGAG concentration (see Methods) (Fig. 8). The normal
compressive resistance increased with increasing sGAG concentration for both populations;
however, the newborn aggrecan exhibited a much stronger resistance to compressive stress
than the adult aggrecan, even at the same sGAG concentration.
4. Discussion
In this study, direct visualization of individual human aggrecan molecules enabled
separation of the proteolytic and biosynthetic variations in aggrecan ultrastructural and
nanomechanical properties between age groups. Accumulated proteolytic activity,
characterized by the increased heterogeneity and fragmentation of aggrecan was seen in both
adult aggrecan populations. The variation in cell biosynthetic processes with age was
reflected especially in the difference in GAG chain lengths, and to additional degrees by the
full length aggrecan core protein length, end-to-end distance and extension ratio. In
particular, the length of GAG side chains within single aggrecan molecules significantly
decreased with age. In addition, the roles of various GAG side chain components were
quantified by selective removal of KS-GAG and CS-GAG constituents. As a result of these
structural changes, the uncompressed aggrecan volume (height) and compression resistance
were also reduced in adult aggrecan populations.
4.1 Age-related aggrecan structural changes due to proteolytic variations
The progressive proteolytic modification of aggrecan during aging is evident in the presence
of smaller aggrecan fragments in both newborn and adult aggrecan populations (Fig. 1). The
adult aggrecan population contained markedly more fragmented aggrecan monomers (LCP <
300 nm, Fig. 2a), showing the accumulation of enzymatically cleaved aggrecan with
increasing age, e.g., monomers with partial CS-GAG domains or free G1-domains. In vivo,
aggrecan core proteins are cleaved by a number of enzymes, primarily aggrecanases (a
disintegrin and metalloproteinase with thrombospondin motifs, ADAMTS-4 and
ADAMTS-5) and matrix metalloproteinases (MMPs) (Flannery et al., 1992; Sandy et al.,
1991; Tortorella et al., 2002). Aggrecanases cleave aggrecan core protein in the
interglobular domain (IGD) to produce free G1 domains (G1-NITEGE) (Sandy et al., 1991),
and more efficiently (Tortorella et al., 2002) at distinctive sites within the CS region to leave
fragments with partially retained GAG chains and core protein lengths ~ 25 – 75% of the
full length aggrecan. MMPs can cleave the core protein in the IGD (Flannery et al., 1992) to
produce another type of free G1 domain (G1-VDIPEN). These proteolytic activities are
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directly reflected in the observed high concentration of aggrecan fragments with reduced
LCP within the adult population (Fig. 2a). While G1-free fragments are expected to diffuse
out of cartilage after cleavage, G1-associated fragments retain the capability of binding to
hyaluronan. Thus, these fragments are known to accumulate in cartilage tissue with age
(Lark et al., 1997; Yasumoto et al., 2003). Compared to intact aggrecan with a half-life of ~
3.5 years in the inter-territorial matrix, the free-G1 domains have a much longer resident
time in the matrix of 19 – 25 years (Maroudas et al., 1998; Verzijl et al., 2001). The
accumulation of free G1-domains has been hypothesized to be detrimental to cartilage, as
they can worsen biomechanical properties by competing with full length aggrecan on the
hyaluronan binding sites (Mercuri et al., 1999).
The accumulation of proteolytically-derived aggrecan fragments is diminished for the
newborn aggrecan, reflected by the greater values of average LCP (Fig. 2a), and smaller
difference with its full aggrecan subpopulation (Fig. 2b). This aggrecan structure
comparison thus provided direct observation on the cumulative age-related proteolytic
effects on cartilage aggrecan heterogeneity and polydispersity at the individual molecular
level. In vivo, the differences of cartilage aggrecan polydispersity between these two age
groups are expected to be more pronounced than the observation here (Figs. 1 and 2), as the
density-based D1D1 sample preparation procedure has removed a large portion of GAG-
deplete aggrecan fragments (Roughley and White, 1980), and thus, reduced the
polydispersity to a larger extent in the adult aggrecan population (Bayliss and Ali, 1978;
Dudhia et al., 1996; Plaas et al., 2001; Roughley and White, 1980).
4.2 Age-related aggrecan core protein structural changes due to biosynthesis variations
With the advantages of direct visualization, we were able to specifically pick the full length
aggrecan subpopulation, which had globular domains identified at both the N- and C-termini
(Fig. 1c, f). The full length aggrecan monomers have not undergone enzymatic
modifications and, hence, only reflect the results of chondrocyte biosynthetic processes.
Moreover, the metabolic half life of full length aggrecan is ~ 3.4 years (Maroudas et al.,
1998), shorter than the age difference between the newborn and adult (both 29 and 38 year
old) human subjects. Hence, the full length aggrecan found in the adult populations are most
likely synthesized later in the subject’s life time. In the absence of proteolytic modifications,
the significantly greater values of full length aggrecan core protein trace length, LCP,
provide direct evidence of the age-related variations in the chondrocyte biosynthetic
activities. It is likely that this age-related decrease in core protein length is not a direct result
of variation in core protein synthesis, but rather an indirect consequence of variations in the
sulfation pattern, number and length of GAG side chains (Dudhia, 2005; Roughley and
White, 1980).
4.3 Age-related glycosaminoglycan chain structural changes due to biosynthesis
variations
Although previous chromatography (Carney et al., 1985; Deutsch et al., 1995; Inerot et al.,
1978; Plaas et al., 1997) and electron microscopy (Buckwalter et al., 1994) studies have
suggested significant shortening of GAG chain lengths with increasing age, this study for
the first time provided detailed ultrastructural characterization and comparison of GAGs
attached to human aggrecan based on the information from individual molecules (Fig. 3).
Within each individual full length aggrecan (Fig. 1c, f), GAG chains of the adult aggrecan
are considerably shorter than those of newborn aggrecan (Fig. 3a).
For the newborn population, most of the GAG chains are CS-GAGs, whereas for the adult
population, the observed GAG chains are likely a mixture of CS- and KS-GAGs. The
differences in both chain lengths (Brown et al., 1998; Huckerby et al., 1999; Santer et al.,
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1982) and number of chains (Elliott and Gardner, 1979) between KS and CS decrease with
age. The narrower distribution of LGAG seen in the individual adult aggrecan monomers
(Fig. 3a) may also reflect the decreased GAG length heterogeneity due to the decreased
length differences between CS and KS with age (Brown et al., 1998; Huckerby et al., 1999;
Santer et al., 1982), or between CS chains in the CS1 and CS2 regions (Rodriguez et al.,
2006).
4.4 Age-related variations in aggrecan conformation and compressive nanomechanical
properties
The end-to-end distance, Ree, and extension ratio, Ree/LCP, of the newborn aggrecan are
markedly greater than the adult population (Fig. 2c, d). Newborn human aggrecan molecules
thus adapt a more extended conformation compared to the adult aggrecan, owing to the
stronger steric and electrostatic repulsion as a result of longer GAG chains and greater net
charge densities. The conformational entropic effects are less important, leading to a more
extended, less coil-like molecular conformation (Flory, 1953). Similarly, due to the stronger
GAG-GAG repulsion, the newborn population also demonstrates greater initial height and
higher compressive stiffness compared to the adult aggrecan upon compression
nanomechanical test at physiological-like conditions (Fig. 7). The higher electrostatic forces
for the newborn population arise from the greater number of charges per GAG chain, greater
number of GAG chains, and possibly smaller GAG-GAG molecule spacing along the core
protein. The higher nonelectrostatic forces are related to the larger dimensions of aggrecan
(i.e, LCP and LGAG). Macroscopically, the compressive modulus of cartilage correlates well
with GAG fixed charge density (Williamson et al., 2001). At the nanoscale, we have shown
that the molecular structure and dimension of aggrecan and GAGs also affect the
compressive behavior of aggrecan (Dean et al., 2006; Lee et al., 2010). At physiologic-like
ionic strength (0.10 M), higher compressive stress was observed for the newborn aggrecan
than the adult aggrecan even at the same sulfated GAG (sGAG) density (Fig. 8). This
difference is due to the larger nonelectrostatic (steric and entropic) components (Bathe et al.,
2005; Comper and Laurent, 1978), as well as variation in the heterogeneity of charge and
electrostatic potential distributions within the end-grafted aggrecan layer (Buschmann and
Grodzinsky, 1995; Dean et al., 2003). This difference further demonstrates the importance
of aggrecan molecular architecture and associated heterogeneous, spatially nonuniform
charge distribution in determining aggrecan molecular mechanics and cartilage tissue
stiffness.
4.5 Structure and distribution of different GAG side chain components
Using the 29-year-old human aggrecan population as the model system, we directly
identified the spatial distribution of different KS- and CS-GAG side chain components along
the aggrecan core protein, and explored and identified their contributions to the structure and
properties of aggrecan by selective removal of each constituent (Fig. 4). The KS-GAGs only
make up a small fraction of the side chains, as removal of KS-GAGs did not lead to marked
changes in the brush-like aggrecan structure (Fig. 4d). On the other hand, the majority of the
GAGs are CS-GAG chains, where removal of CS-GAGs essentially transforms aggrecan
into a linear core protein, with only traces of shorter KS-GAGs near the N-terminal (Figs. 4f
and 5). This observation thus provides the direct experimental evidence that supports the
previous hypothesis on the structure and spatial distribution of aggrecan side chain
constituents (Hardingham and Fosang, 1992; Ng et al., 2003).
4.6 Contribution of GAG side chains to aggrecan conformation
Removal of both KS-GAG and CS-GAG significantly reduced the core protein trace length,
LCP (Fig. 6a). Because neither keratanase II nor chondroitinase ABC modifies the amino
acid sequence and physical contour length of the core protein (Oike et al., 1980), the
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decrease in the trace length, LCP, can be attributed to a less extended short range
conformation of the core protein, and the local coiling and aggregation of amino acid units
due to hydrophobic interactions or electrostatic attraction. These short range conformation
changes can take place at the length scale beyond the resolution of AFM imaging (~ 2 nm),
and thus, result in reduced measured values of LCP. This effect is more pronounced for the
CS-removed aggrecan, given the presence of strikingly more CS-GAGs than KS-GAGs
within each aggrecan.
Interestingly, removal of KS-GAG chains had negligible effects on the distribution of the
end-to-end distance, Ree, or the extension ratio, Ree/LCP (Fig. 6b, c). This observation
suggests that the KS-GAG constituents play minor roles in determining aggrecan molecular
conformation and deformation, given the small number of KS-GAGs, the shorter chain
lengths and much smaller number of negative charges compared to CS-GAGs. By
comparison, removal of CS-GAG chains led to significant decreases in Ree and Ree/LCP
(Fig. 6b, c). Since CS-GAGs contribute to most of the negative charges of aggrecan, CS-
GAG-absent aggrecan behaves more similarly to linear protein molecules, with only traces
of shorter GAG chains visible near one end of the core protein, presumably the KS-GAG
chains close to the N-terminal (Fig. 5). These few short KS-GAG chains thus have minimal
impact on the intra-molecular steric, electrostatic repulsion, and nanomechanical properties
of aggrecan, consistent with the observation that the KS-removed aggrecan behave similar to
the full length aggrecan (Fig. 6).
4.7 Implications regarding age-related cartilage tissue degradation and repair
Age-related weakening of aggrecan is known to be directly related to function changes in
articular cartilage. Decreases in cartilage modulus and increases in hydraulic permeability of
cartilages with age may be attributed to the weaker molecular stiffness of full length
aggrecan (Figs. 4 and 5), as well as the higher concentration of enzymatically cleaved G1-
associated fragments that are bound to hyaluronan. In addition, in vivo, aggrecan molecules
are entrapped within the collagen fibrillar network in a pre-strained state, with molecular
strains ~ 40 – 60% for macroscopically uncompressed cartilage (Wight et al., 1991). Under
these finite molecular strains, differences in compressive resistance between the newborn
and adult aggrecan at the same GAG concentration are even more prominent (Fig. 8). These
results give direct experimental evidence of progressive changes in human cartilage
properties that may result from changes at the molecular-level, further elucidating the
relation between aggrecan monomer structure and biomechanical properties of cartilage.
Interestingly, the biosynthesis-related structural and mechanical differences observed here
between the extracted newborn versus adult aggrecan are similar to the differences observed
with aggrecan synthesized by adult equine bone marrow stromal cells (BMSCs) versus
chondrocytes from the same animals (Lee et al., 2010). The BMSC-synthesized aggrecan
monomers show nanostructural and nanomechanical properties superior to the aggrecan
synthesized by adult equine chondrocytes, largely due to differences in GAG chain length.
Consequently, BMSC-aggrecan also exhibits higher compressive stresses than adult
cartilage aggrecan at the same sGAG concentration (Kopesky et al., 2010; Lee et al., 2010).
5. Conclusions
In this study, the age-related structure and property changes of aggrecan monomers from
human articular cartilage were quantified at the length scales of individual molecules and
physiological-like molecular assemblies. While previous biochemical studies have reported
age-related changes in large ensembles of human cartilage aggrecan, this study provides
direct evidence of the modifications by proteolytic and biosynthetic processes on the
structure, conformation and mechanical behavior of aggrecan related to individual
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molecules. These molecular-level changes, including accumulation of fragmented aggrecan,
reduction in aggrecan and CS-GAG size (LCP, LGAG), changes in conformation (Ree, Ree/
LCP), and decrease in aggrecan compressive stiffness are characteristics of cartilage aging in
vivo, and directly affect the tissue function of cartilage and the risk of osteoarthritis. AFM-
based direct visualization of individual aggrecan has enabled us to separate the full-length
and fragmented aggrecan populations, and therefore de-convolute the effects of changes in
proteolytic cleavage and chondrocyte biosynthesis mechanisms. In addition, the roles of CS-
GAG and KS-GAG side chains on aggrecan conformation were distinguished via this direct
visualization method. This study provides the knowledge basis to link certain age- and
osteoarthritis-related changes in cartilage tissue to fundamental molecular processes that
take place at the nanometer length scale. It is hoped that the information presented here will
aid further progress in the field of osteoarthritis research, including detecting early-stage
disease, documenting the disease progression, as well as assessing and optimizing treatment
interventions.
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Figure 1.
Tapping mode AFM height images of (a, b, c) newborn and (d, e, f) 38-year old adult human
aggrecan monomers. Globular domains are indicated by arrows (a and d). An example of
core protein trace, LCP, end-to-end distance, Ree, and GAG chain trace, LGAG, are shown in
(c).
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Figure 2.
Histograms and box-and-whisker plots of structural parameter distributions of newborn and
38-year-old adult human aggrecan monomer core proteins: (a) trace length, LCP, of all
observed aggrecan, (b) trace length, LCP, of full length aggrecan, (c) end-to-end distance,
Ree, of full length aggrecan, and (d) extension ratio, Ree/LCP, of full length aggrecan. *: p <
0.01 between the newborn and adult human aggrecan populations via Mann-Whitney U test.
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Figure 3.
Histograms and box-and-whisker plots of newborn and 38-year-old adult human aggrecan
monomer GAG side chain trace length, LGAG, distributions: (a) individual aggrecan, (b) all
observed aggrecan, (c) full length aggrecan. *: p < 0.0001 between the newborn and adult
human aggrecan populations via Mann-Whitney U test.
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Figure 4.
Tapping mode AFM height images of (a, b) untreated, (c, d) keratanase II-treated and (e, f)
chondroitinase ABC-treated 29 year old adult human aggrecan monomers. An example of
core protein trace, LCP, and end-to-end distance, Ree, are shown in (b).
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Figure 5.
Tapping mode AFM height images of chondroitinase ABC-treated aggrecan monomers. The
presence of short GAG side chains, presumably KS-GAGs, are visualized near one end of
the core proteins (arrows), likely within the KS-domain along the core protein.
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Figure 6.
Histograms and box-and-whisker plots of the structural parameter distributions of 29-year-
old full length adult human aggrecan monomers: (a) core protein trace length, LCP, (b) end-
to-end distance, Ree, and (c) extension ratio, Ree/LCP. Only full length aggrecan monomers
with indentifiable G1 and G3 globular domains are included. *: p < 0.05 for each population
compared with the other two populations via Mann-Whitney U test.
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Figure 7.
(a–d) Three dimensional height images (at ~ 3 nN applied normal force) and compressed
aggrecan layer height, H, versus applied normal force, F, curves of end-grafted (a,c)
newborn and (b,d) adult human aggrecan layers, measured via contact mode AFM imaging
on an aggrecan and hydroxyl-terminated self-assembled monolayer (OH-SAM) micro-
patterned surface (top right schematic). Each data point represents the average of eight
different scan locations under the same normal force, the SDs are smaller than the size of the
data symbols. (e–f) Normal force, F, versus distance, D, curves of end-grafted (e) newborn
and (f) adult human aggrecan layers, measured via AFM-based colloidal force spectroscopy.
The probe tip approached the substrate perpendicular to the plane of the substrate (bottom
right schematic). Each curve represents the average of 30 different locations on the aggrecan
pattern, the SDs are smaller than the width of the data curves. (g) Comparison of the H
versus F (open triangles, replotted from c and d) and F versus D (dashed lines, replotted
from e and f) measurements at 0.01 M ionic strength. All the experiments were conducted in
NaCl aqueous solutions at 0.001 – 1.0 M ionic strengths using a gold-coated spherical
colloidal probe tip (R ~ 2.5 µm), functionalized with OH-SAM.
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Figure 8.
Stress versus sGAG concentration curves converted from force-distance curves in Fig. 7e
and f (0.1 M NaCl). Each curve is an average of 30 approaches at different locations on the
aggrecan pattern. The 95% confidence intervals of each averaged curve are smaller than the
width of the data curves.
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